Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02009449
Title A Phase 1 Study of AM0010 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ARMO BioSciences
Indications

colorectal cancer

pancreatic carcinoma

lung non-small cell carcinoma

melanoma

renal cell carcinoma

ovarian cancer

prostate cancer

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Pembrolizumab

Carboplatin

Gemcitabine

Docetaxel

Pazopanib

Capecitabine

Paclitaxel

Cisplatin

Pegilodecakin

Nab-paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.